The Truth and Consequences of the COURAGE Trial

Journal of the American College of Cardiology

Volumn 50, Issue 16, 2007, Pages 1598-1603

  Kereiakes, Dean J ^a,k   Teirstein, Paul S ^b,k   Sarembock, Ian J ^c,k   Holmes Jr , David R ^d,k   Krucoff, Mitchell W ^e,k   O'Neill, William W ^f,k   Waksman, Ron ^g,k   Williams, David O ^h,k   Popma, Jeffrey J ^i,k   Buchbinder, Maurice ^b,k   Mehran, Roxana ^i,k   Meredith, Ian T ^j,k   Moses, Jeffrey W ^i,k   Stone, Gregg W ^i,k  

^a The Carl & Edyth Lindner Center for Research & Education   (United States)

^b SCRIPPS CLINIC   (United States)

^c CHRIST HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g WASHINGTON HOSPITAL CENTER   (United States)

^h RHODE ISLAND HOSPITAL   (United States)

ⁱ TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NewYork Presbyterian Hospital   (United States)

^k MonasHeart   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CARDIAC PATIENT; CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL ISCHEMIA; PATIENT COMPLIANCE; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETREATMENT; TREATMENT OUTCOME;

EID: 34948893828     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.07.063     Document Type: Review

References (43)

1. Al Suwaidi J., Holmes D.R., Salam A.M., et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J 147 (2004) 815-822
2. Babapulle M.N., Joseph L., Belisel P., et al. A hierarchial Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 363 (2004) 583-591
3. Mauri L., Hsieh W., Massaro J.M., et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
4. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
5. Mehta S.R., Cannon C.P., Fox K.A.A., et al. Routine vs. selective invasive strategies in patients with acute coronary syndromes-a collaborative meta-analysis of randomized trials. JAMA 293 (2005) 2908-2917
6. Bavry A.A., Kumbhani D.J., Rassi A.N., et al. Benefit of early invasive therapy in acute coronary syndromes-a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 48 (2006) 1319-1325
7. Henderson R.A., Pocock S.J., Clayton T.C., et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 42 (2003) 1161-1170
8. Parisi A.F., Folland E.D., Hartigan P., and Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 326 (1992) 10-16
9. Hueb W.A., Bellotti G., deOliveira S.A., et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 26 (1995) 1600-1605
10. Pitt B., Waters D., Brown W.V., et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 341 (1999) 70-76
11. Hueb W., Lopes N.H., Gersh B.J., et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II)-a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115 (2007) 1082-1089
12. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 35 (2007) 1503-1516
13. Centers for Disease Control and Prevention. Prevalence of heart disease. MMWR Surveill Summ 56 (2007) 113-118
14. Anderson H.V., Shaw R.E., Brindis R.G., et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol 39 (2002) 1096-1103
15. Boden W.E., O'Rourke R.A., Teo K.K., et al., Veterans Affairs Cooperative Studies Program. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Am Heart J 151 (2006) 1173-1179
16. Katritsis D.G., and Ioannidis J.P.A. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease-a meta-analysis. Circulation 111 (2005) 2906-2912
17. Hoffman S.N., TenBrook J.A., Wolf M.P., et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
18. Mercado N., Wijns W., Serruys P.W., et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 130 (2005) 512-519
19. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124
20. Serruys P.W., Ong A.T.L., van Herwerden L.A., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. The final analysis of the Arts Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581
21. Brooks M.M., Frye R.L., Genuth S., et al. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Am J Cardiol 97 (2006) 9G-19G
22. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49 (2007) 1600-1606
23. Stone G.W., Mehran R., Dangas G., Lansky A.J., Kornowski R., and Leon M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation 104 (2001) 642-647
24. Hirsh A., Windhausen F., Tijssen J.G., Verheugt F.W., Cornel J.H., de Winter R.J., and Invasive Versus Conservative Treatment in Unstable Coronary Syndrome (ICTUS) Investigators. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with nonST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study. Lancet 369 (2007) 827-835
25. Hannan E.L., Racz M., Holmes D.R., et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 113 (2006) 2406-2412
26. van den Brand M.J., Rensing B.J., Morel M.A., et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 39 (2002) 559-564
27. Nikolsky E., Gruberg L., Patil C.V., et al. Percutaneous coronary interventions in diabetic patients: is complete revascularization important?. J Invas Cardiol 16 (2004) 102-106
28. Boden W.E., O'Rourke R.A., Teo K.K., et al. The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardiol 99 (2007) 208-212
29. Boden W.E. Interpreting the COURAGE trial: it takes COURAGE to alter our belief system. Clev Clin J Med 74 (2007) 623-633
30. Stone G.W., Ellis S.G., Cox D.A., et al., TAXUS IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
31. Moses J.W., Leon M.B., Popma J.J., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in pts with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
32. Serruys P.W., Kutryk M.J., and Ong A.T. Coronary artery stents. N Engl J Med 354 (2006) 483-495
33. Rodriguez A.E., Bernardi V., Navia J., et al. Argentine Randomized Study: Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II): 30 days and one year follow-up results. J Am Coll Cardiol 37 (2001) 51-58
34. Macaya C., Garcia H., Serruys P.W., et al. Sirolimus-eluting stent versus surgery and bare metal stenting in the treatment of diabetic patients with multivessel disease-a comparison between ARTS II and ARTS I. (abstr). Circulation 112 (2005) II655
35. Cohen D.J., Dulisse B., Zhang J., et al. Cost-effectiveness of PCI with or without drug-eluting stents vs. bypass surgery for treatment of multivessel coronary disease: 1 year results from the ARTS I and ARTS II trials. (abstr). Circulation 112 (2005) II550
36. SYNTAX study: TAXUS drug-eluting stent versus coronary artery bypass surgery for the treatment of narrowed arteries. Available at: http://www.clinicaltrials.gov/ct/show/NCT00114972?order=1. Accessed August 2006.
37. Comparison of two treatments for multivessel coronary artery disease in individuals with diabetes (FREEDOM). Available at: http://www.clinicaltrials.gov/ct/show/NCT00086450?order=1. Accessed October 2006.
38. Smith D. The CARDIA trial protocol. Heart 89 (2003) 1125-1126
39. Coronary Artery Revascularization in Diabetes (VA CARDS). Available at http://www.clinicaltrials.gov/ct/show/NCT00326196?order=1. Accessed August 2006.
40. Weintraub W.S. Late breaking trial presentation (2007) Paper presented at: Annual Meeting of the American College of Cardiology; March 24; New Orleans, LA.
41. Mehta R.H., Roe M.T., Chen A.Y., et al. Changing practice for nonST-segment elevation acute coronary syndromes: trends from the CRUSADE 1uality improvement initiative. (abstr). Circulation 112 (2005) II793
42. Steinberg B.A., Steg P.G., Bhatt D.L., Fonarow G.C., Zeymer U., Cannon C.P., and REACH Registry Investigators. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol 99 (2007) 1212-1215
43. Gallagher E.J., Viscoli C.M., and Horwitz R.I. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 270 (1993) 742-744